Envista’s (NVST) Neutral Rating Reiterated at Piper Sandler

Piper Sandler reaffirmed their neutral rating on shares of Envista (NYSE:NVST) in a report issued on Thursday,Benzinga reports. Piper Sandler currently has a $28.00 price target on the stock, up from their previous price target of $26.00.

Several other analysts have also weighed in on NVST. Barclays decreased their price target on Envista from $34.00 to $32.00 and set an “overweight” rating on the stock in a report on Thursday, June 11th. Citigroup began coverage on shares of Envista in a research note on Wednesday, April 15th. They set a “neutral” rating and a $29.00 price objective for the company. JPMorgan Chase & Co. boosted their price objective on shares of Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Wall Street Zen downgraded shares of Envista from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 9th. Finally, Morgan Stanley raised their target price on shares of Envista from $19.00 to $21.00 and gave the stock an “equal weight” rating in a report on Friday, April 24th. Six equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $29.31.

Envista Trading Up 3.1%

Shares of NYSE NVST opened at $28.22 on Thursday. Envista has a 1-year low of $18.77 and a 1-year high of $30.42. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.43 and a quick ratio of 2.06. The business’s 50 day moving average is $26.03 and its two-hundred day moving average is $26.02. The stock has a market capitalization of $4.59 billion, a P/E ratio of 48.65, a PEG ratio of 1.49 and a beta of 0.86.

Envista (NYSE:NVST) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.07. The business had revenue of $730.50 million during the quarter, compared to analyst estimates of $716.11 million. Envista had a return on equity of 7.88% and a net margin of 3.33%.The company’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period last year, the company earned $0.26 EPS. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, research analysts expect that Envista will post 1.53 EPS for the current year.

Institutional Investors Weigh In On Envista

Several hedge funds and other institutional investors have recently modified their holdings of the business. Pzena Investment Management LLC purchased a new position in Envista during the 2nd quarter valued at $30,494,000. Pallas Capital Advisors LLC purchased a new stake in Envista in the second quarter worth $513,000. Deutsche Bank AG purchased a new stake in Envista in the second quarter worth $9,481,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in Envista in the second quarter worth $25,000. Finally, OneDigital Investment Advisors LLC bought a new stake in shares of Envista during the second quarter worth $655,000.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.